vs

Side-by-side financial comparison of Norwegian Cruise Line Holdings (NCLH) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.

Norwegian Cruise Line Holdings is the larger business by last-quarter revenue ($2.2B vs $1.5B, roughly 1.5× BeOne Medicines Ltd.). BeOne Medicines Ltd. runs the higher net margin — 4.4% vs 0.6%, a 3.8% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 6.4%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $21.5M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 1.2%).

Norwegian Cruise Line (NCL) is an American cruise line founded in Norway in 1966, headquartered in Miami-Dade County, Florida, and incorporated in the Bahamas. It is the fourth-largest cruise line in the world by passengers, controlling about 8.6% of the total worldwide share of the cruise market by passengers as of 2021. It is wholly owned by parent company Norwegian Cruise Line Holdings.

BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.

NCLH vs ONC — Head-to-Head

Bigger by revenue
NCLH
NCLH
1.5× larger
NCLH
$2.2B
$1.5B
ONC
Growing faster (revenue YoY)
ONC
ONC
+26.4% gap
ONC
32.8%
6.4%
NCLH
Higher net margin
ONC
ONC
3.8% more per $
ONC
4.4%
0.6%
NCLH
More free cash flow
ONC
ONC
$358.4M more FCF
ONC
$379.8M
$21.5M
NCLH
Faster 2-yr revenue CAGR
ONC
ONC
Annualised
ONC
41.2%
1.2%
NCLH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NCLH
NCLH
ONC
ONC
Revenue
$2.2B
$1.5B
Net Profit
$14.3M
$66.5M
Gross Margin
41.0%
90.5%
Operating Margin
8.3%
12.4%
Net Margin
0.6%
4.4%
Revenue YoY
6.4%
32.8%
Net Profit YoY
-94.4%
143.8%
EPS (diluted)
$0.08
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NCLH
NCLH
ONC
ONC
Q4 25
$2.2B
$1.5B
Q3 25
$2.9B
$1.4B
Q2 25
$2.5B
$1.3B
Q1 25
$2.1B
$1.1B
Q4 24
$2.1B
$1.1B
Q3 24
$2.8B
$1.0B
Q2 24
$2.4B
$929.2M
Q1 24
$2.2B
$751.7M
Net Profit
NCLH
NCLH
ONC
ONC
Q4 25
$14.3M
$66.5M
Q3 25
$419.3M
$124.8M
Q2 25
$30.0M
$94.3M
Q1 25
$-40.3M
$1.3M
Q4 24
$254.5M
$-151.9M
Q3 24
$474.9M
$-121.3M
Q2 24
$163.4M
$-120.4M
Q1 24
$17.4M
$-251.2M
Gross Margin
NCLH
NCLH
ONC
ONC
Q4 25
41.0%
90.5%
Q3 25
47.1%
86.1%
Q2 25
42.1%
87.5%
Q1 25
38.7%
85.2%
Q4 24
38.0%
85.8%
Q3 24
45.2%
83.0%
Q2 24
38.7%
85.1%
Q1 24
36.7%
83.4%
Operating Margin
NCLH
NCLH
ONC
ONC
Q4 25
8.3%
12.4%
Q3 25
25.5%
11.5%
Q2 25
16.8%
6.7%
Q1 25
9.4%
1.0%
Q4 24
10.2%
-7.0%
Q3 24
24.6%
-12.0%
Q2 24
14.4%
-11.5%
Q1 24
10.0%
-34.8%
Net Margin
NCLH
NCLH
ONC
ONC
Q4 25
0.6%
4.4%
Q3 25
14.3%
8.8%
Q2 25
1.2%
7.2%
Q1 25
-1.9%
0.1%
Q4 24
12.1%
-13.5%
Q3 24
16.9%
-12.1%
Q2 24
6.9%
-13.0%
Q1 24
0.8%
-33.4%
EPS (diluted)
NCLH
NCLH
ONC
ONC
Q4 25
$0.08
$0.05
Q3 25
$0.86
$0.08
Q2 25
$0.07
$0.06
Q1 25
$-0.09
$0.00
Q4 24
$0.55
$-0.10
Q3 24
$0.95
$-0.09
Q2 24
$0.35
$-0.09
Q1 24
$0.04
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NCLH
NCLH
ONC
ONC
Cash + ST InvestmentsLiquidity on hand
$209.9M
$4.5B
Total DebtLower is stronger
$13.7B
$836.4M
Stockholders' EquityBook value
$2.2B
$4.4B
Total Assets
$22.5B
$8.2B
Debt / EquityLower = less leverage
6.21×
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NCLH
NCLH
ONC
ONC
Q4 25
$209.9M
$4.5B
Q3 25
$166.8M
$4.0B
Q2 25
$184.0M
$2.8B
Q1 25
$184.4M
$2.5B
Q4 24
$190.8M
$2.6B
Q3 24
$332.5M
$2.7B
Q2 24
$594.1M
$2.6B
Q1 24
$559.8M
$2.8B
Total Debt
NCLH
NCLH
ONC
ONC
Q4 25
$13.7B
$836.4M
Q3 25
$13.6B
Q2 25
$12.6B
Q1 25
$12.9B
Q4 24
$11.8B
Q3 24
$11.8B
Q2 24
$11.9B
Q1 24
$12.0B
Stockholders' Equity
NCLH
NCLH
ONC
ONC
Q4 25
$2.2B
$4.4B
Q3 25
$2.2B
$4.1B
Q2 25
$1.6B
$3.8B
Q1 25
$1.4B
$3.5B
Q4 24
$1.4B
$3.3B
Q3 24
$1.1B
$3.4B
Q2 24
$693.1M
$3.4B
Q1 24
$362.1M
$3.4B
Total Assets
NCLH
NCLH
ONC
ONC
Q4 25
$22.5B
$8.2B
Q3 25
$22.2B
$7.6B
Q2 25
$21.6B
$6.3B
Q1 25
$21.4B
$5.8B
Q4 24
$20.0B
$5.9B
Q3 24
$19.8B
$5.8B
Q2 24
$20.1B
$5.7B
Q1 24
$19.8B
$5.7B
Debt / Equity
NCLH
NCLH
ONC
ONC
Q4 25
6.21×
0.19×
Q3 25
6.22×
Q2 25
8.05×
Q1 25
9.09×
Q4 24
8.26×
Q3 24
10.35×
Q2 24
17.19×
Q1 24
33.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NCLH
NCLH
ONC
ONC
Operating Cash FlowLast quarter
$459.1M
$417.3M
Free Cash FlowOCF − Capex
$21.5M
$379.8M
FCF MarginFCF / Revenue
1.0%
25.4%
Capex IntensityCapex / Revenue
19.5%
2.5%
Cash ConversionOCF / Net Profit
32.21×
6.28×
TTM Free Cash FlowTrailing 4 quarters
$-1.2B
$941.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NCLH
NCLH
ONC
ONC
Q4 25
$459.1M
$417.3M
Q3 25
$236.6M
$402.6M
Q2 25
$714.9M
$263.6M
Q1 25
$679.2M
$44.1M
Q4 24
$399.3M
$75.2M
Q3 24
$172.5M
$188.4M
Q2 24
$670.9M
$-95.6M
Q1 24
$807.2M
$-308.6M
Free Cash Flow
NCLH
NCLH
ONC
ONC
Q4 25
$21.5M
$379.8M
Q3 25
$-726.5M
$354.5M
Q2 25
$381.2M
$219.8M
Q1 25
$-846.0M
$-12.3M
Q4 24
$155.8M
$-17.3M
Q3 24
$-195.5M
$54.7M
Q2 24
$330.2M
$-205.5M
Q1 24
$548.3M
$-465.1M
FCF Margin
NCLH
NCLH
ONC
ONC
Q4 25
1.0%
25.4%
Q3 25
-24.7%
25.1%
Q2 25
15.1%
16.7%
Q1 25
-39.8%
-1.1%
Q4 24
7.4%
-1.5%
Q3 24
-7.0%
5.5%
Q2 24
13.9%
-22.1%
Q1 24
25.0%
-61.9%
Capex Intensity
NCLH
NCLH
ONC
ONC
Q4 25
19.5%
2.5%
Q3 25
32.8%
3.4%
Q2 25
13.3%
3.3%
Q1 25
71.7%
5.0%
Q4 24
11.5%
8.2%
Q3 24
13.1%
13.3%
Q2 24
14.4%
11.8%
Q1 24
11.8%
20.8%
Cash Conversion
NCLH
NCLH
ONC
ONC
Q4 25
32.21×
6.28×
Q3 25
0.56×
3.22×
Q2 25
23.83×
2.79×
Q1 25
34.71×
Q4 24
1.57×
Q3 24
0.36×
Q2 24
4.10×
Q1 24
46.51×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NCLH
NCLH

Passenger$1.5B67%
Onboard And Other$734.4M33%

ONC
ONC

Segment breakdown not available.

Related Comparisons